vol1 - Page 363

 DEA embarks on its redefinition of reality by stating:
 _if an individual's pressure was higher than
 the average, he was thought to have glaucoma;
 ..... if the pressure was below the norm, he was
 thought not to have glaucomaŽ _' [Spaeth_
 directs G-Vol. II_ ppo 4_5_ _{ 9-67] It is
 now known that this is not thel_[gper method
 for diagnosing glaucoma. [/__]_i
 _The proper diagnosis of glaucoma has always been, and
 remains, evidence of damage to the optic disc_ Glaucoma is the
 disease, buts as Spaeth so incisively states:
 At this point, [intraocular] pressure is the
 only factor we know of which effects the
 course of the disease. If the [intraocular]
 pressure can be lowered sufficiently_ it
 usually a_s the course of the
 diseases _i
 DEA ignores the distinction Spaeth is making between
 the goal of glaucoma treatment (retention of visual function) and
 ..... the medfcal means employed to achieve this goal (reduction of
 intraocular pressure). DEA_s inability to distinguish the
 treatment objective from the treatment itself is evidenced when
 DEA states:
 Effective treatment for glaucoma involves the
 use of pharmaceutical agents o o ° that
 prevent progressive optic nerve damage ....
 For a treatment to be effective, it must
 lower intraocular pressure sufficiently to
 prevent additional damage to the optic nerve
 .... Xn additions it must beable to
 sustain the lowered pressure and preserve
 visual full, Son for the patient's
 llfetime. _w-_I
 161/ DEA Briefs _ 68_ at 41.
 162/ Affidavit of Dr. George Spaeth _ 13.
 !63/ DEA Briefs _ 69 at 4i_42o DEA is not describing a
 treatment indications it is defining a cure.
 .... _ 57 -